Desferrioxamine and CP94 (1,2diethyl-3 -hydroxypyridin-4-one) are metal che
lators used or proposed for use in the clinical treatment of iron overload.
Recent data on their capacity to deplete intracellular iron led to the con
jecture that the differences observed arose from the different membrane-pen
etration properties of the two compounds.
The time-course of accumulation and subsequent release of [C-14]CP94 by the
rat visceral yolk sac in-vitro was compared with that of [C-14]desferrioxa
mine and for I-125- labelled poly(vinylpyrrolidone), a marker for fluid-pha
se endocytosis. The results indicate that [C-14]CP94 crosses the plasma and
lysosome membranes rapidly whereas [C-14]desferrioxamine and I-125-labelle
d poly(vinylpyrrolidone) are effectively incapable of crossing these membra
nes, entering cells only by endocytosis.
It is concluded that although CP94 readily enters and leaves cells, desferr
ioxamine has the potential to accumulate to high concentration in the lysos
omes and complex with intralysosomal iron. The results support and extend t
he proposed correlation between pharmacological activity and capacity for m
embrane penetration.